|
| |
|
 |
Revista |
 |
|
|
|
|
|
|
|
|
|
Acceso al texto completo de la revista MULTIPLE SCLEROSIS para socios de la SEN. Hacer click en http://em.sen.es/biblioteca/index.htm... |
|
|
|
|
 |
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
ESTUDIO BENEFIT - Betaferon en Primer Brote |
|
|
|
|
|
|
|
|
|
|
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
REVISION SOBRE INTERFERON BETA-1B |
|
|
|
|
|
|
|
|
|
|
Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
Placebo-controlled multicentre randomised trial of interferon |
|
|
|
|
|
|
|
|
 |
|
Placebo-controlled multicentre randomised trial of interferon b-1b in treatment of secondary progressive multiple sclerosis... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
El interferón beta-1b es eficaz en la esclerosis multiple de... |
|
|
|
|
|
|
|
|
 |
|
Análisis RM de los resultados de un ensayo multicéntrico, aleatorizado, a doble ciego y controlado con placebo... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
Systemic Recombinant Human Interferon-B Treatment |
|
|
|
|
|
|
|
|
 |
|
Systemic Recombinant Human Interferon-B Treatment of Relapsing-Remiting Multiple Sclerosis: Pilot Study Análisis and Six-Year Follow-Up... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
Intramuscular Interferon Beta-la for Disease Progression |
|
|
|
|
|
|
|
|
 |
|
Intramuscular Interferon Beta-la for Disease Progression in Relapsing Multiple Sclerosis... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
A randomized, double-blind, dosecomparison study |
|
|
|
|
|
|
|
|
 |
|
A randomized, double-blind, dosecomparison
study of weekly interferon
-1a in relapsing MS... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
Randomized controlled trial of interferonbeta-1a |
|
|
|
|
|
|
|
|
 |
|
Randomized controlled trial of interferonbeta-
1a in secondary progressive MS... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
Evidence of interferon b-1a dose response in relapsing-remitting |
|
|
|
|
|
|
|
|
 |
|
Evidence of interferon b-1a dose
response in relapsing-remitting MS
The OWIMS Study... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
| |
|
|
 |
|
Multicentre, randomised, double blind, placebo controlled, |
|
|
|
|
|
|
Multicentre, randomised, double blind, placebo controlled,
phase III study of weekly, low dose, subcutaneous interferon
beta-1a in secondary progressive multiple sclerosis... |
|
 |
| |
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
| |
|
|
Copolymer 1 reduces relapse rate and improves disability |
|
|
|
|
|
|
|
|
 |
|
Copolymer 1 reduces relapse rate and improves disability in relapsing-remiting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial... |
|
|
|
|
|
Seguir
Leyendo |
|
|
|
|
|
|
|
|
Referencias
bibliográficas
